JP2017503527A5 - - Google Patents

Download PDF

Info

Publication number
JP2017503527A5
JP2017503527A5 JP2016565119A JP2016565119A JP2017503527A5 JP 2017503527 A5 JP2017503527 A5 JP 2017503527A5 JP 2016565119 A JP2016565119 A JP 2016565119A JP 2016565119 A JP2016565119 A JP 2016565119A JP 2017503527 A5 JP2017503527 A5 JP 2017503527A5
Authority
JP
Japan
Prior art keywords
prostate cancer
individual
collection
genes
expression level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016565119A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017503527A (ja
JP6666852B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/011824 external-priority patent/WO2015109234A1/en
Publication of JP2017503527A publication Critical patent/JP2017503527A/ja
Publication of JP2017503527A5 publication Critical patent/JP2017503527A5/ja
Application granted granted Critical
Publication of JP6666852B2 publication Critical patent/JP6666852B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016565119A 2014-01-16 2015-01-16 前立腺がん再発の予後に関する遺伝子発現パネル Expired - Fee Related JP6666852B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461928361P 2014-01-16 2014-01-16
US61/928,361 2014-01-16
PCT/US2015/011824 WO2015109234A1 (en) 2014-01-16 2015-01-16 Gene expression panel for prognosis of prostate cancer recurrence

Publications (3)

Publication Number Publication Date
JP2017503527A JP2017503527A (ja) 2017-02-02
JP2017503527A5 true JP2017503527A5 (enExample) 2018-03-01
JP6666852B2 JP6666852B2 (ja) 2020-03-18

Family

ID=52435027

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016565119A Expired - Fee Related JP6666852B2 (ja) 2014-01-16 2015-01-16 前立腺がん再発の予後に関する遺伝子発現パネル

Country Status (7)

Country Link
US (3) US10364469B2 (enExample)
EP (1) EP3094747B1 (enExample)
JP (1) JP6666852B2 (enExample)
CN (2) CN112322735A (enExample)
AU (3) AU2015206336B2 (enExample)
CA (1) CA2935720A1 (enExample)
WO (1) WO2015109234A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10364469B2 (en) 2014-01-16 2019-07-30 Illumina, Inc Gene expression panel for prognosis of prostate cancer recurrence
CA2971129A1 (en) 2015-01-22 2016-07-28 The Board Of Trustees Of The Leland Stanford Junior University Methods and systems for determining proportions of distinct cell subsets
EP3655955B1 (en) * 2017-07-21 2025-04-09 The Board of Trustees of the Leland Stanford Junior University Systems and methods for analyzing mixed cell populations
CN111868260B (zh) 2017-08-07 2025-02-21 约翰斯霍普金斯大学 用于评估和治疗癌症的方法和材料
CN107699564B (zh) * 2017-10-23 2019-09-20 中国科学院苏州生物医学工程技术研究所 人前列腺癌早期诊断用长链非编码rna序列及其应用
US10769783B2 (en) * 2018-02-09 2020-09-08 Case Western Reserve University Predicting prostate cancer biochemical recurrence using combined nuclear NF-KB/P65 localization and gland morphology
DE202019005627U1 (de) 2018-04-02 2021-05-31 Grail, Inc. Methylierungsmarker und gezielte Methylierungssondenpanels
US11348240B2 (en) * 2018-05-14 2022-05-31 Tempus Labs, Inc. Predicting total nucleic acid yield and dissection boundaries for histology slides
US11348661B2 (en) 2018-05-14 2022-05-31 Tempus Labs, Inc. Predicting total nucleic acid yield and dissection boundaries for histology slides
US11741365B2 (en) 2018-05-14 2023-08-29 Tempus Labs, Inc. Generalizable and interpretable deep learning framework for predicting MSI from histopathology slide images
US11348239B2 (en) 2018-05-14 2022-05-31 Tempus Labs, Inc. Predicting total nucleic acid yield and dissection boundaries for histology slides
US10957041B2 (en) 2018-05-14 2021-03-23 Tempus Labs, Inc. Determining biomarkers from histopathology slide images
US20200004928A1 (en) * 2018-06-29 2020-01-02 Roche Sequencing Solutions, Inc. Computing device with improved user interface for interpreting and visualizing data
US20210318324A1 (en) 2018-07-05 2021-10-14 The Board Of Regents Of The University Of Oklahoma Gene signatures for cancer characterization and methods of use
WO2020069350A1 (en) 2018-09-27 2020-04-02 Grail, Inc. Methylation markers and targeted methylation probe panel
WO2020092808A1 (en) 2018-10-31 2020-05-07 Regents Of The University Of Minnesota Methods for predicting a response to bevacizumab or platinum-based chemotherapy or both in patients with ovarian cancer
GB2615975B (en) * 2019-02-14 2023-11-29 Mirvie Inc Methods and systems for determining a pregnancy-related state of a subject
GB2626699B (en) * 2019-05-08 2024-11-20 Oxford BioDynamics PLC Chromosome Conformation Markers of Prostate Cancer and Lymphoma
CN110706749B (zh) * 2019-09-10 2022-06-10 至本医疗科技(上海)有限公司 一种基于组织器官分化层次关系的癌症类型预测系统和方法
GB201915464D0 (en) * 2019-10-24 2019-12-11 Uea Enterprises Ltd Novel biomarkers and diagnostic profiles for prostate cancer
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
KR102139315B1 (ko) * 2020-02-27 2020-07-29 이화여자대학교 산학협력단 Tnfrsf19 유전자의 dna 메틸레이션 변화를 이용한 알츠하이머병 치매 조기진단 마커
KR102139313B1 (ko) * 2020-02-27 2020-07-29 이화여자대학교 산학협력단 알츠하이머병 치매 조기 진단을 위한 후성 유전학적 진단 키트 개발
JP7784997B2 (ja) * 2020-06-18 2025-12-12 オンタリオ・インスティテュート・フォー・キャンサー・リサーチ(オーアイシーアール) 前立腺癌の分子分類器
EP3960877A1 (en) * 2020-08-31 2022-03-02 Koninklijke Philips N.V. Prediction of a response of a prostate cancer subject to therapy or personalization of therapy of a prostate cancer subject
WO2022147503A1 (en) * 2020-12-31 2022-07-07 Tempus Labs, Inc. Predicting total nucleic acid yield and dissection boundaries for histology slides
WO2023058100A1 (ja) 2021-10-04 2023-04-13 国立大学法人 東京大学 構造多型の検出方法、プライマーセット及びプライマーセットの設計方法
CN121569350A (zh) * 2023-05-03 2026-02-24 米尔维公司 用于确定对象妊娠相关状态的方法与系统

Family Cites Families (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4469863A (en) 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US5235033A (en) 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
US5216141A (en) 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
GB8822228D0 (en) 1988-09-21 1988-10-26 Southern E M Support-bound oligonucleotides
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
DE3924454A1 (de) 1989-07-24 1991-02-07 Cornelis P Prof Dr Hollenberg Die anwendung von dna und dna-technologie fuer die konstruktion von netzwerken zur verwendung in der chip-konstruktion und chip-produktion (dna chips)
US5252743A (en) 1989-11-13 1993-10-12 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
US5386023A (en) 1990-07-27 1995-01-31 Isis Pharmaceuticals Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling
US5602240A (en) 1990-07-27 1997-02-11 Ciba Geigy Ag. Backbone modified oligonucleotide analogs
US5770358A (en) 1991-09-18 1998-06-23 Affymax Technologies N.V. Tagged synthetic oligomer libraries
CA2124087C (en) 1991-11-22 2002-10-01 James L. Winkler Combinatorial strategies for polymer synthesis
US5324633A (en) 1991-11-22 1994-06-28 Affymax Technologies N.V. Method and apparatus for measuring binding affinity
US5644048A (en) 1992-01-10 1997-07-01 Isis Pharmaceuticals, Inc. Process for preparing phosphorothioate oligonucleotides
EP0675966B1 (en) 1992-02-19 2004-10-06 The Public Health Research Institute Of The City Of New York, Inc. Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids
US5583211A (en) 1992-10-29 1996-12-10 Beckman Instruments, Inc. Surface activated organic polymers useful for location - specific attachment of nucleic acids, peptides, proteins and oligosaccharides
US5491074A (en) 1993-04-01 1996-02-13 Affymax Technologies Nv Association peptides
US5858659A (en) 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
US5472672A (en) 1993-10-22 1995-12-05 The Board Of Trustees Of The Leland Stanford Junior University Apparatus and method for polymer synthesis using arrays
US5429807A (en) 1993-10-28 1995-07-04 Beckman Instruments, Inc. Method and apparatus for creating biopolymer arrays on a solid support surface
US6090555A (en) 1997-12-11 2000-07-18 Affymetrix, Inc. Scanned image alignment systems and methods
US5578832A (en) 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
US5637684A (en) 1994-02-23 1997-06-10 Isis Pharmaceuticals, Inc. Phosphoramidate and phosphorothioamidate oligomeric compounds
EP0758403B1 (en) 1994-05-05 1998-06-24 Beckman Instruments, Inc. Oligonucleotide repeat arrays
US5571639A (en) 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US5795716A (en) 1994-10-21 1998-08-18 Chee; Mark S. Computer-aided visualization and analysis system for sequence evaluation
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US5599695A (en) 1995-02-27 1997-02-04 Affymetrix, Inc. Printing molecular library arrays using deprotection agents solely in the vapor phase
US5624711A (en) 1995-04-27 1997-04-29 Affymax Technologies, N.V. Derivatization of solid supports and methods for oligomer synthesis
US5545531A (en) 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
US5968740A (en) 1995-07-24 1999-10-19 Affymetrix, Inc. Method of Identifying a Base in a Nucleic Acid
WO1997014028A2 (en) 1995-10-11 1997-04-17 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and method
US5658734A (en) 1995-10-17 1997-08-19 International Business Machines Corporation Process for synthesizing chemical compounds
US6022963A (en) 1995-12-15 2000-02-08 Affymetrix, Inc. Synthesis of oligonucleotide arrays using photocleavable protecting groups
EP0902885A4 (en) 1996-05-16 2006-09-27 Affymetrix Inc SYSTEMS AND METHODS FOR DETECTION OF BRANDED PRODUCTS
US5786146A (en) 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US6083697A (en) 1996-11-14 2000-07-04 Affymetrix, Inc. Chemical amplification for the synthesis of patterned arrays
US6297006B1 (en) 1997-01-16 2001-10-02 Hyseq, Inc. Methods for sequencing repetitive sequences and for determining the order of sequence subfragments
US6327410B1 (en) 1997-03-14 2001-12-04 The Trustees Of Tufts College Target analyte sensors utilizing Microspheres
US6023540A (en) 1997-03-14 2000-02-08 Trustees Of Tufts College Fiber optic sensor with encoded microspheres
DE69829402T2 (de) 1997-10-31 2006-04-13 Affymetrix, Inc. (a Delaware Corp.), Santa Clara Expressionsprofile in adulten und fötalen organen
US6087102A (en) 1998-01-07 2000-07-11 Clontech Laboratories, Inc. Polymeric arrays and methods for their use in binding assays
US6428752B1 (en) 1998-05-14 2002-08-06 Affymetrix, Inc. Cleaning deposit devices that form microarrays and the like
US6287776B1 (en) 1998-02-02 2001-09-11 Signature Bioscience, Inc. Method for detecting and classifying nucleic acid hybridization
EP1051245A1 (en) 1998-02-06 2000-11-15 Affymetrix, Inc. (a California Corporation) Method of quality control in manufacturing processes
JP3944996B2 (ja) 1998-03-05 2007-07-18 株式会社日立製作所 Dnaプローブアレー
US6031078A (en) 1998-06-16 2000-02-29 Millennium Pharmaceuticals, Inc. MTbx protein and nucleic acid molecules and uses therefor
US6277628B1 (en) 1998-10-02 2001-08-21 Incyte Genomics, Inc. Linear microarrays
US6355431B1 (en) 1999-04-20 2002-03-12 Illumina, Inc. Detection of nucleic acid amplification reactions using bead arrays
WO2000063437A2 (en) 1999-04-20 2000-10-26 Illumina, Inc. Detection of nucleic acid reactions on bead arrays
US20030207295A1 (en) 1999-04-20 2003-11-06 Kevin Gunderson Detection of nucleic acid reactions on bead arrays
US20040121364A1 (en) 2000-02-07 2004-06-24 Mark Chee Multiplex nucleic acid reactions
US6913884B2 (en) 2001-08-16 2005-07-05 Illumina, Inc. Compositions and methods for repetitive use of genomic DNA
US7611869B2 (en) 2000-02-07 2009-11-03 Illumina, Inc. Multiplexed methylation detection methods
US7955794B2 (en) 2000-09-21 2011-06-07 Illumina, Inc. Multiplex nucleic acid reactions
US7582420B2 (en) 2001-07-12 2009-09-01 Illumina, Inc. Multiplex nucleic acid reactions
DK1259643T3 (da) 2000-02-07 2009-02-23 Illumina Inc Fremgangsmåde til detektion af nukleinsyre ved anvendelse af universel priming
US6770441B2 (en) 2000-02-10 2004-08-03 Illumina, Inc. Array compositions and methods of making same
JP2001244419A (ja) * 2000-02-28 2001-09-07 Hitachi Ltd 高周波モジュール及び移動体検知モジュール
US6489606B1 (en) 2000-04-07 2002-12-03 Cidra Corporation Bragg grating sensor system with spectral response or code division multiplexing
ATE377093T1 (de) * 2000-07-07 2007-11-15 Visigen Biotechnologies Inc Sequenzbestimmung in echtzeit
US20040018491A1 (en) 2000-10-26 2004-01-29 Kevin Gunderson Detection of nucleic acid reactions on bead arrays
US6964850B2 (en) * 2001-11-09 2005-11-15 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
US8288641B2 (en) * 2001-12-27 2012-10-16 Intel Corporation Portable hand-held music synthesizer and networking method and apparatus
US20040029151A1 (en) * 2002-04-09 2004-02-12 Affymetrix, Inc. Molecular genetic profiling of gleason grades 3 and 4/5 prostate cancer
US7441703B2 (en) 2002-08-20 2008-10-28 Illumina, Inc. Optical reader for diffraction grating-based encoded optical identification elements
US7164533B2 (en) 2003-01-22 2007-01-16 Cyvera Corporation Hybrid random bead/chip based microarray
US20050227252A1 (en) 2002-08-20 2005-10-13 Moon John A Diffraction grating-based encoded articles for multiplexed experiments
US7399643B2 (en) 2002-09-12 2008-07-15 Cyvera Corporation Method and apparatus for aligning microbeads in order to interrogate the same
JP2005536769A (ja) 2002-08-20 2005-12-02 シヴェラ コーポレイション 回折格子をベースとする光学同定要素
CA2499037A1 (en) 2002-09-12 2004-03-25 Cyvera Corporation Method and apparatus for labelling using diffraction grating-based encoded optical identification elements
US20040259105A1 (en) 2002-10-03 2004-12-23 Jian-Bing Fan Multiplex nucleic acid analysis using archived or fixed samples
JP2006524035A (ja) * 2002-12-26 2006-10-26 シーマインズ リミテッド ライアビリティ カンパニー 癌の診断、予後診断および治療のための方法および組成物
US20050181394A1 (en) 2003-06-20 2005-08-18 Illumina, Inc. Methods and compositions for whole genome amplification and genotyping
CA2559801A1 (en) 2003-10-01 2005-04-14 Cyvera Corporation Optical reader for diffraction grating-based encoded optical identification elements
US20060023310A1 (en) 2004-02-19 2006-02-02 Putnam Martin A Optical identification element using separate or partially overlapped diffraction gratings
US7339165B2 (en) 2004-07-09 2008-03-04 Hamilton Sundstrand Corporation Dual outlet pyrolyzer for biological agent detection system
EP2194485B1 (en) 2004-11-16 2012-10-17 Illumina, Inc. Method and apparatus for reading coded microbeads
CA2491067A1 (en) 2004-12-24 2006-06-24 Stichting Katholieke Universiteit Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer
US7914988B1 (en) 2006-03-31 2011-03-29 Illumina, Inc. Gene expression profiles to predict relapse of prostate cancer
US8262900B2 (en) 2006-12-14 2012-09-11 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
CN101889074A (zh) 2007-10-04 2010-11-17 哈尔西恩莫尔丘勒公司 采用电子显微镜对核酸聚合物测序
US20120329713A1 (en) 2008-02-21 2012-12-27 Klem Robert E Method for determining likelihood of clinical recurrence or clinically stable disease of prostate cancer after radical prostatectomy
CN102308212A (zh) * 2008-12-04 2012-01-04 加利福尼亚大学董事会 用于确定前列腺癌诊断和预后的材料和方法
NZ596468A (en) * 2009-05-14 2013-11-29 Nestec Sa Biomarkers for determining sensitivity of breast cancer cells to her2-targeted therapy
TWM395976U (en) * 2010-06-30 2011-01-01 Tsung-Hung Wu Electret electroacoustic transducer
IL243203A (en) * 2010-07-27 2017-04-30 Genomic Health Inc Method for using gene expression to determine prognosis of prostate cancer
EP2678448A4 (en) * 2011-02-22 2014-10-01 Caris Life Sciences Luxembourg Holdings S A R L CIRCULATING BIOMARKERS
US20140222443A1 (en) * 2011-06-07 2014-08-07 Kathleen Danenberg Molecular profiling for cancer
DK3179393T3 (da) * 2012-01-31 2020-07-27 Genomic Health Inc Genexpressionsprofilalgoritme og -test til bestemmelse af prognosen for prostatakræft
US20130323739A1 (en) 2012-06-05 2013-12-05 Iris International, Inc. Method for determining recurrence or stable disease after treatment for prostate cancer
WO2014022594A1 (en) 2012-07-31 2014-02-06 Daniel Mercola Stroma biomarkers for prostate cancer prognosis
US10364469B2 (en) 2014-01-16 2019-07-30 Illumina, Inc Gene expression panel for prognosis of prostate cancer recurrence

Similar Documents

Publication Publication Date Title
JP2017503527A5 (enExample)
Joshi et al. Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer
ES2595410T3 (es) Biomarcadores de cáncer
CA2923092C (en) Assessment of the pi3k cellular signaling pathway activity using mathematical modelling of target gene expression
Fu et al. FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer
Fumagalli et al. Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology
JP2010500565A5 (enExample)
JP2014532428A5 (enExample)
Waddell et al. Gene expression profiling of formalin‐fixed, paraffin‐embedded familial breast tumours using the whole genome‐DASL assay
Alsaleem et al. A novel prognostic two-gene signature for triple negative breast cancer
WO2013177245A3 (en) Nano46 genes and methods to predict breast cancer outcome
RU2017146154A (ru) Способы прогнозирования рака предстательной железы
Szász et al. The CIN4 chromosomal instability qPCR classifier defines tumor aneuploidy and stratifies outcome in grade 2 breast cancer
CY1114993T1 (el) Προφιλ εκφρασης γονιδιου για να προβλεπονται εκβασεις καρκινου μαστου
Tang et al. A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer
JP2017507320A5 (enExample)
DK3141617T3 (en) PROCEDURE FOR PREVENTING THE CANCER OF A CANCER ON A PATIENT BY ANALYZING GENEPRESSION
JP2025510477A (ja) メチル化バリアントを使用した腫瘍画分推定
JP2017509351A5 (enExample)
CN102421920B (zh) 用于肿瘤特征和标记物组鉴定,肿瘤分级的方法和用于癌的标记物组
JP2012525818A5 (enExample)
Alonso‐Dominguez et al. PTCH1 expression at diagnosis predicts imatinib failure in chronic myeloid leukaemia patients in chronic phase
Liu et al. Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2+: ERα-breast cancer
Ovaska et al. Integrative analysis of deep sequencing data identifies estrogen receptor early response genes and links ATAD3B to poor survival in breast cancer
Heinemann et al. Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo